| NDC Code | 45802-304-65 |
|---|
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (45802-304-65) |
|---|
| Product NDC | 45802-304 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Alogliptin And Pioglitazone |
|---|
| Non-Proprietary Name | Alogliptin Benzoate And Pioglitazone Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20160408 |
|---|
| Marketing Category Name | NDA AUTHORIZED GENERIC |
|---|
| Application Number | NDA022426 |
|---|
| Manufacturer | Padagis Israel Pharmaceuticals Ltd |
|---|
| Substance Name | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
|---|
| Strength | 12.5; 45 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS] |
|---|